Search research articles
Contact Us
Filters
Showing results (81-90 of 93) with videos related to
Page
of 10
Sort By:
Annals of African Medicine
|
November 18, 2016
Performance of waist circumference and proposed cutoff levels for defining overweight and obesity in Nigerians
Christian I Okafor, Taiwo H Raimi, Ibrahim D Gezawa, et al.
The Nigerian Postgraduate Medical Journal
|
March 16, 2007
Comparative study of the effect of tocotrienols and -tocopherol on fasting serum lipid profiles in patients with mild hypercholesterolaemia: a preliminary report
J N A Ajuluchukwu, N U Okubadejo, M Mabayoje, et al.
Digital Health
|
January 13, 2023
Telemedicine ready or not? A cross-sectional assessment of telemedicine maturity of federally funded tertiary health institutions in Nigeria
Tolulope F Olufunlayo, Oluwadamilola O Ojo, Obianuju B Ozoh, et al.
Alimentary Pharmacology & Therapeutics
|
May 22, 2015
Population pharmacokinetics-pharmacodynamics of vedolizumab in patients with ulcerative colitis and Crohn's disease
M Rosario, N L Dirks, M R Gastonguay, et al.
Alimentary Pharmacology & Therapeutics
|
April 28, 2009
Clinical trial: benefits and risks of immunomodulators and maintenance infliximab for IBD-subgroup analyses across four randomized trials
G R Lichtenstein, R H Diamond, C L Wagner, et al.
British Journal of Clinical Pharmacology
|
April 27, 2016
Brentuximab vedotin, an antibody-drug conjugate, in patients with CD30-positive haematologic malignancies and hepatic or renal impairment
Baiteng Zhao, Robert Chen, Owen A O'Connor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 17, 1998
Phase II trial of paclitaxel and topotecan with granulocyte colony-stimulating factor support in stage IV breast cancer
G F Fleming, J W Kugler, P C Hoffman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 20, 1998
Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, and hydroxyurea with granulocyte colony-stimulating factor support for patients with poor-prognosis cancer of the head and neck
B Brockstein, D J Haraf, K Stenson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 6, 2005
Absence of adverse effects in cynomolgus macaques treated with CNTO 95, a fully human anti-alphav integrin monoclonal antibody, despite widespread tissue binding
Pauline L Martin, Qun Jiao, Joel Cornacoff, et al.
Investigational New Drugs
|
February 12, 2017
Phase II study of the antibody-drug conjugate TAK-264 (MLN0264) in patients with metastatic or recurrent adenocarcinoma of the stomach or gastroesophageal junction expressing guanylyl cyclase C
Khaldoun Almhanna, Maria Luisa Limon Miron, David Wright, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 93) with videos related to
Sort By:
Page
of 10
Annals of African Medicine
|
November 18, 2016
Performance of waist circumference and proposed cutoff levels for defining overweight and obesity in Nigerians
Christian I Okafor, Taiwo H Raimi, Ibrahim D Gezawa, et al.
The Nigerian Postgraduate Medical Journal
|
March 16, 2007
Comparative study of the effect of tocotrienols and -tocopherol on fasting serum lipid profiles in patients with mild hypercholesterolaemia: a preliminary report
J N A Ajuluchukwu, N U Okubadejo, M Mabayoje, et al.
Digital Health
|
January 13, 2023
Telemedicine ready or not? A cross-sectional assessment of telemedicine maturity of federally funded tertiary health institutions in Nigeria
Tolulope F Olufunlayo, Oluwadamilola O Ojo, Obianuju B Ozoh, et al.
Alimentary Pharmacology & Therapeutics
|
May 22, 2015
Population pharmacokinetics-pharmacodynamics of vedolizumab in patients with ulcerative colitis and Crohn's disease
M Rosario, N L Dirks, M R Gastonguay, et al.
Alimentary Pharmacology & Therapeutics
|
April 28, 2009
Clinical trial: benefits and risks of immunomodulators and maintenance infliximab for IBD-subgroup analyses across four randomized trials
G R Lichtenstein, R H Diamond, C L Wagner, et al.
British Journal of Clinical Pharmacology
|
April 27, 2016
Brentuximab vedotin, an antibody-drug conjugate, in patients with CD30-positive haematologic malignancies and hepatic or renal impairment
Baiteng Zhao, Robert Chen, Owen A O'Connor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 17, 1998
Phase II trial of paclitaxel and topotecan with granulocyte colony-stimulating factor support in stage IV breast cancer
G F Fleming, J W Kugler, P C Hoffman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 20, 1998
Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, and hydroxyurea with granulocyte colony-stimulating factor support for patients with poor-prognosis cancer of the head and neck
B Brockstein, D J Haraf, K Stenson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 6, 2005
Absence of adverse effects in cynomolgus macaques treated with CNTO 95, a fully human anti-alphav integrin monoclonal antibody, despite widespread tissue binding
Pauline L Martin, Qun Jiao, Joel Cornacoff, et al.
Investigational New Drugs
|
February 12, 2017
Phase II study of the antibody-drug conjugate TAK-264 (MLN0264) in patients with metastatic or recurrent adenocarcinoma of the stomach or gastroesophageal junction expressing guanylyl cyclase C
Khaldoun Almhanna, Maria Luisa Limon Miron, David Wright, et al.
Page
of 10